TRX2
{{Short description|Dietary supplement by Oxford BioLabs}}{{Multiple issues|{{additional citations|date=January 2025}}
{{Primary sources|date=January 2025}}
{{Notability|date=January 2025}}}}{{Infobox product
| title = TRX2
| image =
| caption =
| inventor =
| launch year = 2011
| company = Oxford BioLabs
| available = Available
| notes = Dietary supplement
| url = {{URL|https://www.oxfordbiolabs.com/collections/trx2|oxfordbiolabs.com}}
}}
TRX2 is a dietary supplement marketed for individuals with hair loss. It is manufactured and sold by Oxford BioLabs in the United Kingdom,{{cite news|last=Tyler|first=Richard|title=Thomas Whitfield's German roots help hair loss product launch|url=https://www.telegraph.co.uk/finance/yourbusiness/8248046/Thomas-Whitfields-German-roots-help-hair-loss-product-launch.html|accessdate=23 July 2012|newspaper=The Daily Telegraph|date=9 January 2011}}{{cite news|last=Tyler|first=Richard|title=Thomas Whitfield: The Oxford student who plans to make baldness a thing of the past|url=https://www.telegraph.co.uk/finance/yourbusiness/brightideas/4268434/Thomas-Whitfield-The-Oxford-student-who-plans-to-make-baldness-a-thing-of-the-past.html|accessdate=23 July 2012|newspaper=The Daily Telegraph|date=16 January 2009}} marketed in 2011.
Etymology and Formulation
The name TRX2 is said to be derived from the Ancient Greek word trichos, meaning hair and the number 2 stands for second generation.{{cite web|title=Oxford BioLabs|url=https://www.oxfordbiolabs.com/|publisher=Oxford BioLabs|accessdate=1 December 2017}} The proper word for hair in Ancient Greek is however thrix (θρίξ).Liddell, H.G. & Scott, R. (1940). A Greek-English Lexicon. revised and augmented throughout by Sir Henry Stuart Jones. with the assistance of. Roderick McKenzie. Oxford: Clarendon Press.
TRX2 contains amino acids and vitamins. Its ingredients are L-carnitine, L-tartaric acid, potassium chloride, L-leucine, isoleucine, valine, nicotinic acid, and biotin.{{cite web|title=Carnipure|url=http://www.lonza.com/products-services/nutrition/human-nutrition/health-ingredients/carnipure.aspx|publisher=Lonza|accessdate=October 22, 2012|format=Web}}
The product is a dietary supplement, not a drug, and hence it does not need approval by the U.S. Food and Drug Administration (FDA).{{cite news|last=Edwards|first=Jim|title=Pharma's 4 Best Shots at a Cure for Baldness|url=https://www.cbsnews.com/news/pharmas-4-best-shots-at-a-cure-for-baldness/|access-date=1 August 2012|newspaper=CBSNews.com|date=12 January 2011|agency=CBS News|format=Web|quote=it's actually just another dietary supplement and as such doesn't need to be approved by the FDA.}}{{cite web|title=Minoxidil Alternatives|url=http://www.hairloss-research.org/UpdateMinoxidilAlternatives6-11.html|publisher=MPB Research|accessdate=1 August 2012|format=Web}}
Oxford BioLabs
Oxford BioLabs was founded in August 2008 as a Limited Liability Company in England and Wales by former scientists of the University of Oxford, including biochemist and entrepreneur Thomas Whitfield. The company have German based Research Facilities located in Biopark Regensburg, Regensburg, Germany. According to an article published by The Daily Telegraph the company is bootstrapped by its founders as well as by NESTA and the National Council for Graduate Entrepreneurship (NCGE).{{cite news|title=Thomas Whitfield's German roots help hair loss product launch|url=http://ncee.org.uk/thomas-whitfields-german-roots-help-hair-loss-product-launch/|accessdate=1 August 2012|newspaper=NCEE|date=10 January 2011|agency=NCEE|format=Web}}
Clinical Studies
TRX2 has been tested by Oxford Biolabs in a clinical study.{{cite web|title=TRX2® HAIR SUPPLEMENT CLINICAL STUDY
|url=https://www.oxfordbiolabs.com/blogs/oxford-research/trx2-hair-supplement-clinical-study|publisher=Oxford BioLabs|accessdate=1 December 2017|format=Web}} In the study, 59 male and female volunteers showing signs of alopecia completed 18 months of therapy, receiving either TRX2 or a placebo.
The results of the study showed that 26 (out of a total 29) participants who had taken TRX2 recorded an increase of at least 10% in the number of hair strands in the evaluation area and/or a 10% increase in hair weight.
The third-party studies took place in 2019 and were conducted by the European Research Institute Dermatest.
Controversy
In January 2014 the UK Advertising Standards Authority upheld a complaint against TRX2 and Oxford Biolabs, citing that advertisements that the company had run for TRX2 were misleading and in breach of EU advertising codes. The company agreed and changed their advertising in line with the code of conduct.{{cite web|title=ASA Adjudication on Oxford Biolabs Ltd|url=http://www.asa.org.uk/Rulings/Adjudications/2014/1/Oxford-Biolabs-Ltd/SHP_ADJ_244720.aspx%23.VDVh0X3LfK5|publisher=Advertising Standards Authority|accessdate=1 December 2017|format=Web|url-status=bot: unknown|archiveurl=https://archive.today/20141008160959/http://www.asa.org.uk/Rulings/Adjudications/2014/1/Oxford-Biolabs-Ltd/SHP_ADJ_244720.aspx%23.VDVh0X3LfK5|archivedate=8 October 2014}}
See also
References
{{reflist}}
External links
- [https://www.oxfordbiolabs.com/collections/trx2 TRX2], Product Website